Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.3.1985

Decreased Expression of LKB1 Correlates with Poor Prognosis in Hepatocellular Carcinoma Patients Undergoing Hepatectomy  

Huang, Yue-Han (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Chen, Zhen-Kun (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Huang, Ka-Te (Department of Pathology, The First Affiliated Hospital of Wenzhou Medical College)
Li, Peng (Department of Pathology, The First Affiliated Hospital of Wenzhou Medical College)
He, Bin (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Guo, Xu (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Zhong, Jun-Qiao (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Zhang, Qi-Yu (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Shi, Hong-Qi (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Song, Qi-Tong (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Yu, Zheng-Ping (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Shan, Yun-Feng (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.3, 2013 , pp. 1985-1988 More about this Journal
Abstract
Aim: To study any correlation of LKB1 expression with prognosis in hepatocellular carcinoma (HCC) cases. Methods: A total of 70 HCC patients and 20 primary intrahepatic stone patients in the first affiliated hospital of Wenzhou Medical College were enrolled in this study. LKB1 expression was detected by immunohistochemistry. Patients were followed-up and prognostic factors were evaluated. Result: LKB1 expression was decreased in the HCC samples. Loss of LKB1 expression in HCC was significantly related to histologic grade (P=0.010), vascular invasion (P=0.025) and TMN stage (P=0.011). Patients showing negative LKB1 expression had a significantly shorter disease-free and overall survival than those with positive expression (P = 0.001, P=0.000, respectively). Multivariate Cox regression analysis indicated that LKB1 expression level was an independent factor of survival (P = 0.033). Conclusion: HCC patients with decreased expression LKB1 have a poor prognosis. The loss of LKB1 expression is correlated with a lower survival rate.
Keywords
LKB1; expression; hepatocellular carcinoma; survival; prognosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Avizienyte E, Loukola A, Roth S, et al (1999). LKB1 somatic mutations in sporadic tumors. Am J Pathol, 154, 677-81.   DOI   ScienceOn
2 Cha HJ, Kim J, Hong SM, et al(2012). Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma. Ann Surg Oncol, 19, 404-11.   DOI   ScienceOn
3 Chen HP, Shieh JJ, Chang CC, et al (2013). Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut, 62, 606-15.   DOI   ScienceOn
4 Esteller M, Avizienyte E, Corn PG, et al (2000). Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene, 19, 164-8.   DOI   ScienceOn
5 Fenton H, Carlile B, Montgomery EA, et al (2006). LKB1 protein expression in human breast cancer. Appl Immunohistochem Mol Morphol, 14, 146-53.   DOI   ScienceOn
6 Fernandez P, Carretero J, Medina PP, et al (2004). Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations. Oncogene, 23, 5084-91.   DOI   ScienceOn
7 Gao Y, Ge G, Ji H(2011). LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor. Protein Cell, 2, 99-107.   DOI   ScienceOn
8 Herrmann JL, Byekova Y, Athar M (2011). Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers. Cancer Lett, 306, 1-9.   DOI   ScienceOn
9 Hezel AF, Gurumurthy S, Granot Z, et al (2008). Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol, 28, 2414-25.   DOI   ScienceOn
10 Kim DW, Chung HK, Park KC, et al (2007). Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC). Mol Endocrinol, 21, 3039-49.   DOI   ScienceOn
11 Li PD, Zhang WJ, Zhang MY, et al (2012). Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients. Med Oncol, 29, 3070-6.   DOI   ScienceOn
12 Miyoshi H, Deguchi A, Nakau M, et al (2009). Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+/- mice. Cancer Sci, 100, 2046-53.   DOI   ScienceOn
13 Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D (2012). Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res, 14, R35.   DOI   ScienceOn
14 Nakau M, Miyoshi H, Seldin MF, et al (2002). Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res, 62, 4549-53.
15 Sahin F, Maitra A, Argani P, et al (2003). Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod Pathol, 16, 686-91.   DOI   ScienceOn
16 Shackelford DB, Shaw RJ (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer, 9, 563-75.   DOI   ScienceOn
17 Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM (2002). The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res, 8, 2085-90.
18 Su GH, Hruban RH, Bansal RK, et al (1999). Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol, 154, 1835-40.   DOI   ScienceOn
19 Takeuchi Y, Ikeda F, Moritou Y, et al (2012). The impact of patatinlike phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. J Gastroenterol.
20 Yang H, Zhai G, Ji X, et al (2012). LAPTM4B allele $^*2$ is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma. PLOS ONE, 7, e34984.   DOI
21 Zha TZ, Hu BS, Yu HF, et al (2012). Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Tumour Biol, 33, 2125-34.   DOI   ScienceOn
22 Zhuang ZG, Di GH, Shen ZZ, Ding J, Shao ZM (2006). Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol Cancer Res, 4, 843-9.   DOI   ScienceOn